|
Market Closed -
Nasdaq
16:00:00 2026-11-10 EST
|
After hours 17:33:38 | |||
| 250.83 USD | -6.75% |
|
251.64 | +0.32% |
| 11-09 | Goldman Sachs Adjusts Price Target on Moderna to $195 From $137 | MT |
| 11-09 | Piper Sandler Adjusts Price Target on Moderna to $305 From $230 | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Sector Biopharmaceuticals
| Capi. | Sales Growth | Profitability | Finances | EV / Sales | P/E | |
|---|---|---|---|---|---|---|
 | 109B | - | ||||
| 1,258B | |||||
| 679B | |||||
| 518B | |||||
| 390B | |||||
| 367B |
- Stock Market
- Stocks
- MRNA Stock
- Charts Moderna, Inc.
- Sector Chart
Select your edition
All financial news and data tailored to specific country editions
